These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29087518)

  • 21. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.
    Buchheidt D; Baust C; Skladny H; Ritter J; Suedhoff T; Baldus M; Seifarth W; Leib-Moesch C; Hehlmann R
    Clin Infect Dis; 2001 Aug; 33(4):428-35. PubMed ID: 11462176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?
    Morton CO; White PL; Barnes RA; Klingspor L; Cuenca-Estrella M; Lagrou K; Bretagne S; Melchers W; Mengoli C; Caliendo AM; Cogliati M; Debets-Ossenkopp Y; Gorton R; Hagen F; Halliday C; Hamal P; Harvey-Wood K; Jaton K; Johnson G; Kidd S; Lengerova M; Lass-Florl C; Linton C; Millon L; Morrissey CO; Paholcsek M; Talento AF; Ruhnke M; Willinger B; Donnelly JP; Loeffler J;
    Med Mycol; 2017 Jun; 55(4):402-413. PubMed ID: 28339744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients.
    Lass-Flörl C; Gunsilius E; Gastl G; Freund M; Dierich MP; Petzer A
    Mycoses; 2005; 48 Suppl 1():12-7. PubMed ID: 15826281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galactomannan and Polymerase Chain Reaction-Based Screening for Invasive Aspergillosis Among High-Risk Hematology Patients: A Diagnostic Meta-analysis.
    Arvanitis M; Anagnostou T; Mylonakis E
    Clin Infect Dis; 2015 Oct; 61(8):1263-72. PubMed ID: 26157047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid detection of common pathogenic Aspergillus species by a novel real-time PCR approach.
    Faber J; Moritz N; Henninger N; Zepp F; Knuf M
    Mycoses; 2009 May; 52(3):228-33. PubMed ID: 18643890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspergillus PCR formidable challenges and progress.
    Klingspor L; Loeffler J
    Med Mycol; 2009; 47 Suppl 1():S241-7. PubMed ID: 19253138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Aspergillus PCR protocols for testing serum specimens.
    White PL; Mengoli C; Bretagne S; Cuenca-Estrella M; Finnstrom N; Klingspor L; Melchers WJ; McCulloch E; Barnes RA; Donnelly JP; Loeffler J;
    J Clin Microbiol; 2011 Nov; 49(11):3842-8. PubMed ID: 21940479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of Aspergillus PCR in cerebrospinal fluid for the diagnosis of cerebral aspergillosis.
    Imbert S; Brossas JY; Palous M; Joly I; Meyer I; Fekkar A
    Clin Microbiol Infect; 2017 Nov; 23(11):889.e1-889.e4. PubMed ID: 28642144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
    J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
    Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
    Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
    Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validating PCR for detecting invasive aspergillosis.
    Verweij PE; Klont RR; Donnelly JP
    Br J Haematol; 2004 Oct; 127(2):235-6. PubMed ID: 15461638
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
    El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
    Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular detection of invasive aspergillosis in hematologic malignancies.
    Badiee P; Kordbacheh P; Alborzi A; Ramzi M; Shakiba E
    Infection; 2008 Dec; 36(6):580-4. PubMed ID: 18854937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of invasive aspergillosis by PCR and real-time PCR--benefits and drawbacks].
    Lengerová M; Rácil Z; Hrncírová K; Volfová P; Lochmanová J; Dvoráková D; Mayer J
    Klin Mikrobiol Infekc Lek; 2007 Oct; 13(5):184-9. PubMed ID: 17987567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.
    Aslan M; Oz Y; Aksit F; Akay OM
    Mycoses; 2015 Jun; 58(6):343-9. PubMed ID: 25851634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.
    Boch T; Reinwald M; Postina P; Cornely OA; Vehreschild JJ; Heußel CP; Heinz WJ; Hoenigl M; Eigl S; Lehrnbecher T; Hahn J; Claus B; Lauten M; Egerer G; Müller MC; Will S; Merker N; Hofmann WK; Buchheidt D; Spiess B
    Mycoses; 2015 Dec; 58(12):735-45. PubMed ID: 26497302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
    Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
    Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR.
    Fraczek MG; Kirwan MB; Moore CB; Morris J; Denning DW; Richardson MD
    Mycoses; 2014 Feb; 57(2):69-78. PubMed ID: 23786547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.